Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790101 | Urologic Oncology: Seminars and Original Investigations | 2018 | 20 Pages |
Abstract
Comparative effectiveness research (CER) is imperative for objective and balanced assessment of treatment outcomes. CER that uses administrative databases (AD-CER) affords unique opportunities for large scale data analyses that potentially transcend limitations of small institutional datasets. Prostate cancer has received much attention from the AD-CER research community, whereas non-prostate genitourinary malignancies are less well-studied. The objective of this article is to review the currently available AD-CER that has been published in the non-prostate genitourinary malignancies space.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Daniel C. D.O., David B. D.O., M.B.S., Marc C. M.D., M.S.H.P., F.A.C.S., Alexander M.D., F.A.C.S.,